The physical price of a ticket into space.
As a direct consequence of exposure to microgravity astronauts experience a number of physiological changes, which can have serious medical implications when they return to Earth. Most immediate and significant are the head-ward shift of body fluids and the removal of gravitational loading from bone and muscles, which lead to progressive changes in the cardiovascular and musculoskeletal systems. Cardiovascular adaptations result in an increased incidence of orthostatic intolerance (fainting) post-flight, decreased cardiac output and reduced exercise capacity. Changes in the musculoskeletal system contribute significantly to the impaired functions experienced in the post-flight period. The underlying factor producing these changes is the absence of gravity. Countermeasures, therefore, are designed primarily to simulate Earth-like movements, stresses and system interactions. Exercise is one approach that has received wide operational use and acceptance in both the US and Russian space programmes, and has enabled humans to stay relatively healthy in space for well over a year. Although it remains the most effective countermeasure currently available, significant physiological degradation still occurs. The development of other countermeasures will therefore be necessary for longer duration missions, such as the human exploration of Mars.
Hawkey
Adam
A
School of Sport, Exercise and Health Sciences, University College Chichester, Chichester, West Sussex, UK.
D000222:Adaptation, Physiological; D018488:Bone Demineralization, Pathologic / Q000209:etiology / Q000517:prevention & control; D018493:Cardiovascular Deconditioning / Q000502:physiology*; D005081:Exercise Therapy; D018495:Fluid Shifts / Q000502:physiology; D006801:Humans; D007024:Hypotension, Orthostatic / Q000209:etiology / Q000517:prevention & control; D009133:Muscular Atrophy / Q000209:etiology / Q000517:prevention & control; D011829:Radiation Dosage; D013026:Space Flight; D018489:Space Motion Sickness / Q000209:etiology / Q000517:prevention & control; D014893:Weightlessness / Q000009:adverse effects*; D018544:Weightlessness Countermeasures